Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

Clinical trial NCT07224581 · RECRUITING

Trial details

NCT number: NCT07224581
Sponsor: GRIN Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

GRIN-related Neurodevelopmental Disorder

Start date: 2026-01-05
Primary completion: 2027-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.